Nextremity Solutions Gets FDA’s 510(k) Clearance for Subtalar Joint Fusion System

January 20, 2022

Warsaw, Ind.-based Nextremity Solutions has received the FDA’s 510(k) clearance for its InCore fixation system for the subtalar joint between two tarsal bones in the foot.

The system, which is specifically intended for subtalar joint fusion, features a three-part option for reduction and internal fixation of the bones and joints.

The complex subtalar joint is located below the ankle joint and is formed by the union of the heel and the ankle bones.

View today's stories